Utilidad de la monitorización terapéutica de infliximab en el manejo de la enfermedad inflamatoria intestinal
Background: Primary non-response and secondary loss of response (LOR) are significant problems of biological therapy for inflammatory bowel disease (IBD). Therapeutic drug monitoring (TDM) in IBD patients receiving these drugs can improve outcomes. Aim: To measure serum infliximab levels and anti-...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Language: | Spanish / Castilian |
Published: |
Sociedad Médica de Santiago
2018
|
Subjects: | |
Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001101241 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|